Eugene B. Chang

The paper presents the Human Gut Cell Atlas v1.0, a unified reference of gut cell diversity, revealing how tissue structure influences cellular composition and enabling disease and organoid analysis.

This study identifies Eubacterium rectale's detoxification mechanism, showing its ability to reduce ROS and inflammation in gut cells through glutathione production.

The paper investigates whether persistent inflammation in Crohn's disease is due to environmental triggers or intrinsic epithelial changes by comparing organoid and tissue data from patients in remission.

This study shows that a regular chow diet, not microbial transplant, enables rapid gut microbiome recovery after antibiotics in mice, and that diet is essential for effective fecal microbiota transplant.

The paper identifies non-responder-specific epithelial-stromal-immune ecosystems in Crohn's Disease using single-cell and spatial transcriptomics, linking them to treatment resistance.

This study identifies histopathological and molecular features linked to J-pouch failure in IBD patients using single-cell spatial transcriptomics.

The paper constructs a cell-type-resolved chromatin accessibility atlas in the human intestine and identifies regulatory programs and genetic variants associated with Crohn's disease.

This study shows that early life microbiota exposure shapes adult gastrointestinal motility by influencing enteric nervous system development.

The paper identifies microbiome-modified metabolites associated with functional outcomes in acute brain injury patients.

The paper identifies bacteria that conjugate GABA and tyramine to bile acids in the human gut and shows these conjugates are present in stool and J-pouch contents.

This study shows that host-specific microbiota are essential for maintaining diet-specific metabolic homeostasis, while foreign microbiota impair metabolic fitness in germ-free mice.

This study shows that Bacteroides fragilis from UC patients promotes colitis in genetically susceptible mice, suggesting a role for pathobionts in IBD.

This paper identifies peptide YY (PYY) as a novel antimicrobial peptide produced by Paneth cells with selective antifungal activity against Candida albicans hyphae, maintaining gut fungal commensalism.